UNSPSC 51393402: Bamifylline

This classification denotes a bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZTY15D026H. European Medicines Agency schedules Bamifylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06097MIG. Bamifylline generally arises in the molecular formula C20H27N5O3. The term BAMIFYLLINE is an International Non-Proprietary Name or INN. BAMIFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule bamifylline under HS 29395900 and SITC 54145. As of Q4 2014, BAMIFYLLINE remains the US FDA Preferred Term for this commodity. Bamifylline bears US NLM identifiers UMLS ID C0052945 and NCI Concept Code C76573. SMILES: O=C1N(C(=O)N(C2NC(N(CCN(CCO)CC)C12)CC1CCCCC1)C)C.

UNSPSC 51393402 Bamifylline is a Commodity code representing pharmaceutical products, though the recent state and local opportunity posted under it does not reflect the code's nominal scope. Seminole County, Florida solicited Naloxone and safe drug deactivation systems—harm-reduction medical supplies—rather than Bamifylline, a respiratory stimulant drug. The mismatch suggests either a classification error in the county's tagging or a broader catch-all use of this code for pharmaceutical procurement. The opportunity itself targets community health initiatives and indicates that state and local health departments and county health authorities do procure medical supplies and pharmaceutical products through formal competitive bidding, typically IFB or RFP processes, with compliance requirements including drug-free workplace certification, E-Verify, and federal environmental regulation adherence when funding involves FEMA or similar sources.

The geographic activity visible under this code is limited to a single recent opportunity. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking annual procurement of 1,900 units of Naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building; the response deadline was July 26, 2023. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary termination clause. Vendors must provide unit pricing, maintain specified insurance coverage, and bear all shipping and delivery costs. The code shows minimal recent activity overall, and the single opportunity posted does not represent typical purchases under the Bamifylline classification—suggesting either sparse demand for this specific pharmaceutical or a coding misalignment in the county procurement system.